Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor—Glioma Therapy?
Ni Tong, Zhenqiang He, Yujie Ma, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 62

Showing 26-50 of 62 citing articles:

The roles EpCAM plays to enhance the malignancy of gastric cancer
Xuewei Zhao, Ruixia Zhao, Feng Yang, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 11, pp. 8495-8505
Closed Access | Times Cited: 7
Association of glioma CD44 expression with glial dynamics in the tumour microenvironment and patient prognosis
Zhanxin Du, Yaqing Wang, Jiaqi Liang, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 5203-5217
Open Access | Times Cited: 11
Microglia in pediatric brain tumors: The missing link to successful immunotherapy
Aimée du Chatinier, Irene Querol Velilla, Michaël H. Meel, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 11, pp. 101246-101246
Open Access | Times Cited: 6
Myeloid-Derived Suppressor Cells and Macrophage Polarization in Cancer Immunotherapy
Mohammad‐Salar Hosseini, Mohammad Amin Akbarzadeh, Farhad Jadidi‐Niaragh
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 157-204
Closed Access | Times Cited: 2
Nano-immunotherapeutic strategies for targeted RNA delivery: Emphasizing the role of monocyte/macrophages as nanovehicles to treat glioblastoma multiforme
Amanda‐Lee E. Manicum, Saman Sargazi, Sobia Razzaq, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 71, pp. 103288-103288
Open Access | Times Cited: 8
A novel prognostic risk-scoring system based on m5C methylation regulator-mediated patterns for glioma patients
Yutong Wen, Xiaotong Chen, Runtong Li, et al.
Deleted Journal (2024) Vol. 32, Iss. 2, pp. 200790-200790
Open Access | Times Cited: 1
Tumor immune microenvironment in odontogenic carcinomas: Evaluation of the therapeutic potential of immune checkpoint blockade
Kyu‐Young Oh, Seong‐Doo Hong, Hye‐Jung Yoon
Journal of Oral Pathology and Medicine (2024) Vol. 53, Iss. 3, pp. 217-225
Closed Access | Times Cited: 1
Identifying Diffuse Glioma Subtypes Based on Pathway Enrichment Evaluation
Qiushi Feng, Zehua Dong, Rongfang Nie, et al.
Interdisciplinary Sciences Computational Life Sciences (2024) Vol. 16, Iss. 3, pp. 727-740
Closed Access | Times Cited: 1
β-Mangostin targets and suppresses glioma via STING activation and tumor-associated microglia polarization
Yimin Yang, Xuling Luo, Yaling Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117074-117074
Open Access | Times Cited: 1
Insights of immune cell heterogeneity, tumor-initiated subtype transformation, drug resistance, treatment and detecting technologies in glioma microenvironment
Tongzheng Chen, Wenbin Ma, Xin Wang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 1
Immunological challenges and opportunities in glioblastoma multiforme: A comprehensive view from immune system lens
Jayant Singh Bhardwaj, Shivangi Paliwal, Gautam Singhvi, et al.
Life Sciences (2024) Vol. 357, pp. 123089-123089
Closed Access | Times Cited: 1
Deciphering the Labyrinthine System of the Immune Microenvironment in Recurrent Glioblastoma: Recent Original Advances and Lessons from Clinical Immunotherapeutic Approaches
Elena Anghileri, Monica Patanè, Natalia Di Ianni, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6156-6156
Open Access | Times Cited: 10
Immune Gene Signatures and Immunotypes in Immune Microenvironment Are Associated With Glioma Prognose
Xiang-Xu Wang, Haiyan Cao, Yulong Zhai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
RUNX regulated immune-associated genes predicts prognosis in breast cancer
Jingyue Fu, Handong Sun, Feng Xu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 6
Radiotherapy Induces Innate Immune Responses in Patients Treated for Prostate Cancers
Amrita K. Cheema, Yaoxiang Li, Mary Ventimiglia, et al.
Clinical Cancer Research (2022) Vol. 29, Iss. 5, pp. 921-929
Open Access | Times Cited: 6
MR Imaging–Based In Vivo Macrophage Imaging to Monitor Immune Response after Radiofrequency Ablation of the Liver
Jessica Gois Santana, Alexandra Petukhova-Greenstein, Moritz Gross, et al.
Journal of Vascular and Interventional Radiology (2022) Vol. 34, Iss. 3, pp. 395-403.e5
Open Access | Times Cited: 5
SLC10A3 Is a Prognostic Biomarker and Involved in Immune Infiltration and Programmed Cell Death in Lower Grade Glioma
Weibo Ma, Pengying Mei
World Neurosurgery (2023) Vol. 178, pp. e595-e640
Closed Access | Times Cited: 2
Long noncoding RNA HOXC-AS3 remodels lipid metabolism and promotes the proliferation of transformed macrophages in the glioma stem cell microenvironment by regulating the hnRNPA1/CaM axis
Yujing Sheng, Baomin Chen, Liang Liu, et al.
Heliyon (2023) Vol. 9, Iss. 8, pp. e19034-e19034
Open Access | Times Cited: 2
Immune response to foreign materials in spinal fusion surgery
Cai Jia, Wengang Wang, Peng Cai, et al.
Heliyon (2023) Vol. 9, Iss. 9, pp. e19950-e19950
Open Access | Times Cited: 2
Systematic transcriptome profiling of pyroptosis related signature for predicting prognosis and immune landscape in lower grade glioma
Huihan Yu, Meiting Gong, Jian Qi, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 3
PD-L2 Serves as a Potential Prognostic Biomarker That Correlates With Immune Infiltration and May Predict Therapeutic Sensitivity in Lower-Grade Gliomas
Qijun Xie, Xianlong Huang, Huang Wu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 3
ZNF395 facilitates macrophage polarization and impacts the prognosis of glioma.
Feng Xiao, Jie Shen, Lihui Zhou, et al.
PubMed (2022) Vol. 12, Iss. 9, pp. 4312-4325
Closed Access | Times Cited: 3
Development of an m6A-Related lncRNAs Signature Predicts Tumor Stemness and Prognosis for Low-Grade Glioma Patients
Dahua Xu, Peihu Li, Chunrui Zhang, et al.
Stem Cells International (2024) Vol. 2024, Iss. 1
Open Access
E2F3/5/8 serve as potential prognostic biomarkers and new therapeutic direction for human bladder cancer
Zhilu Gan, Alimujiang Abudurexiti, Xiaogang Hu, et al.
Medicine (2024) Vol. 103, Iss. 2, pp. e35722-e35722
Open Access
Advances in bioengineered CAR T/NK cell therapy for glioblastoma: Overcoming immunosuppression and nanotechnology‐based strategies for enhanced CAR T/NK cell therapy
Nasim Dana, Arezou Dabiri, Majed Bahri Najafi, et al.
Bioengineering & Translational Medicine (2024)
Open Access

Scroll to top